[#DIV28SUPER] NIDA Neuroscience Update, May 27, 2020

• Single Cell Opioid Responses in the Context of HIV (SCORCH) Program Expansion: CNS Data Generation for Chronic Opioid, Methamphetamine, and/or Cocaine Exposures (U01 Clinical Trial Not Allowed)
  (RFA-DA-21-019)
  National Institute on Drug Abuse
  Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.

• Large scale mapping and/or molecular profiling of ensembles and/or cell-types mediating opioid action in the rodent brain (R01 - Clinical Trial Not Allowed)
  (PAR-20-182)
  National Institute on Drug Abuse
  Application Receipt Date(s): October 30, 2020
• Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)

(Note: COVID-19 research related to substance abuse and substance use disorders  is within scope of this FOA)

National Institute on Drug Abuse

National Cancer Institute

(PAR-19-064)

Application Receipt Date(s): June 8, 2020; October 6, 2020; February 8, 2021; June 8, 2021; October 8, 2021, by 5:00 PM local time of applicant organization

 

• Reminder of Notice of Special Interest (NOSI): NHLBI and NIDA Announce Availability of Administrative Supplements for HEAL Awardees to Address Sleep Impairments in OUD Treatment Response and Recovery Outcomes

(NOT-HL-20-746)

Key Dates
Release Date: March 27, 2020
First Available Due Date: June 01, 2020 
Expiration Date: June 02, 2020

NIDA offers Genotyping to Substance Abuse Disorder Investigators

(NOT-DA-20-041)

Submit requests no later than September 14, 2020

 

• NIDA Center for Genetics Studies offers services to generate high quality induced pluripotent stem cells (iPSC) from people who use substances.

Please direct your request to Jonathan D. Pollock, Ph.D.

 

• Other NIDA Funding Opportunities

 

The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services  TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L   in the message body of the email - You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov   301-435-1309

 

 

[#DIV28SUPER] Joint Meeting of the Advisory Councils of NIAAA, NIDA, NCI - May 2020

Hello Division 28 Members!

 

As many of you may know, NIDA, NIAAA, and CRAN Advisory Councils met recently. The presentations from NIDA and NIAAA include resources and information related to substance use disorder and COVID-19, as well as other useful information that may be of interest to you including an update on the ABCD study. These presentations are video archived here.

 

Hope you are all doing well.

 

Wendy J. Lynch, Ph.D.

President, APA Division 28 (Psychopharmacology and Substance Abuse)

Associate Professor of Psychiatry and Neurobehavioral Sciences

Physical Address: 450 Ray C. Hunt Drive (Aurbach Building), Room G164

Mailing Address: PO Box 801402, Charlottesville, VA 22904-1402

434-243-0580 (office)

434-249-3699 (cell)

 

[#DIV28SUPER] Wayne State University adds new Endowed Chair in Addiction and Pain Biology - School of Medicine News - Wayne State University

https://today.wayne.edu/medicine/news/2020/04/29/wayne-state-university-adds-new-endowed-chair-in-addiction-and-pain-biology-37132

Congratulations!

Sent from my iPhone
_____________________ div28SUPER@lists.apa.org _____________________
Div28m members #div28 subscribers corner: http://lists.apa.org

[#DIV28SUPER] Anesthesiology is among the highest risk occupations (including death)

Access to agents with abuse potential is a major determinant of abuse liability.

This paper provides remarkable new quantitative evidence. The hazard has been known for decades, and the authors discuss the likelihood of underestimation.

This paper is unusual in that it links professional organization records with potential for under reporting with an independent death registry that records cause of death.

The risk of death in this profession approaches that of the commercial fishing industry.

Perioperative Medicine | April 2020

Substance Use Disorder in Physicians after Completion of Training in Anesthesiology in the United States from 1977 to 2013

Anesthesiology

Newly Published on April 9, 2020.

doi:https://doi.org/10.1097/ALN.0000000000003310


Sent from my iPhone
_____________________ div28SUPER@lists.apa.org _____________________
Div28m members #div28 subscribers corner: http://lists.apa.org

[#DIV28SUPER] FW: [DIVTRIO] FREE WEBINAR 5/14 at 12pm EST: Work and Unemployment in the Time of COVID-19 with David L. Blustein

Hello All,

 

Here are a couple upcoming FREE and timely webinars in the time of COVID-19:

 

Upcoming Webinars from the COVID-19 Special Task Group (STG) of SCP/CCPTP/ACCTA: Many thanks to the STG members and to our presenters below. These are very important and timely topics. Please join us and help spread the word.

· Work and Unemployment in the Time of COVID-19: Mental Health and Work-Based Implications with David L. Blustein. May 14, 2020, 12:00 - 1:00 pm EST. Register here: https://us02web.zoom.us/webinar/register/WN_6u4-EYM-RPeKEegyFmw7q Unemployment has quickly emerged as a crisis within the pandemic crisis, affecting millions of people around the globe. The COVID-19 crisis has ruptured already fragile systems in nearly all sectors of life, including work, mental health, social and economic disparities, and of course, our physical health. This webinar will review the major mental health and vocational impacts of unemployment and work-based uncertainty that have been evoked by this crisis. Strategies for individuals and communities as well as systemic interventions also will be presented. David L. Blustein is a Professor in the Department of Counseling, Developmental, and Educational Psychology at the Lynch School of Education and Human Development at Boston College.  David is the author of The Psychology of Working: A New Perspective for Career Development, Counseling, and Public Policy and the recently published The Importance of Work in an Age of Uncertainty: The Eroding Experience of Work in America.  He has contributed journal articles, book chapters, and advocacy work on unemployment, integrative mental health and work-based interventions, psychology of working theory, decent work, precarious work, relationships and work, and other aspects of the role of work in people's lives.

· Aging, Ageism, and Intersectionality in the Time of COVID-19 with Katherine Ramos, Maggie Syme, and Kate L. N. Hinrichs. May 20, 2020, 12:00 - 1:00 pm EST. Register here: https://us02web.zoom.us/webinar/register/WN_BY9N6lEWSkGbKmNVQqrEbw. This webinar is specifically curated for counseling psychologists who are either working directly or indirectly with older adult colleagues, clients or with family members who have concerns about their older adult loved ones. Int this webinar, panelist will discuss aging and intersectionality across, age, race/ethnicity, and being LGBTQ+. Lastly, panels and attendees will engage in self-reflection and focus how we as members of Division 17 can be professional and personal allies to older adult populations and colleagues. Panel Q&A w/ a few slides on ageism defined and intersectionality, followed by Q&A. Katherine Ramos Ph.D., is a counseling psychologist and currently an Assistant Professor in the Department of Psychiatry and Behavioral Sciences with Duke University.  She is a current member with APA's Committee on Aging (CONA). She specialized in older adults and palliative care in her clinical training, and her research focuses on the development and implementation of psychosocial interventions for older adults and their caregivers. Maggie Syme, Ph.D., is a counseling psychologist and currently an Associate Professor and Associate Director of Research for the Center on Aging at Kansas State University. She specialized in older adults in her clinical training, and her research focuses on the psychological and socio-cultural factors of sexuality across the lifespan, with specific focus on the role of ageism. Kate L. M. Hinrichs, Ph.D., ABPP is a counseling psychologist in the VA Boston Healthcare System and is board certified in geropsychology. She is also an Assistant Professor of Psychology in the Department of Psychiatry at Harvard Medical School. She specialized in older adults in her clinical training, and her work focuses mainly in LGBTQ+ and aging communities. She is the co-chair of the Aging Committee within Division 44.

[#DIV28SUPER] FW: ECP Special Issue

See note below for a special issue of ECP.

 

 

From: Andrew Huhn <ahuhn1@jhu.edu>
Sent: Monday, May 11, 2020 1:07 PM
To: Lynch, Wendy J (wjl6w) <wjl6w@virginia.edu>
Subject: ECP Special Issue

 

Hi Wendy,

 

Can you forward this message to the Division 28 listserve?

 

Call for Papers: Experimental and Clinical Psychopharmacology

 

Special Issue on: Utilizing translational approaches to advance harm reduction strategies for substance use disorders

 

This special issue will provide an overview of current translational research from both human and non-human animal researchers investigating harm reduction strategies for substance use disorders (SUDs). The goal of this special issue is to highlight new and efficacious strategies to promote harm reduction in both clinical and preclinical models, and to catalyze future translational collaborations in the field. Particular topics of interest include but are not limited to nicotine-containing products such as heat-not-burn products and e-cigarettes, as well as products and strategies that reduce the incidence of opioid overdose including fentanyl test strips, safe injection sites, and safe delivery of heroin, hydromorphone, or other opioids. Another area of interest is research on other treatment outcomes associated with harm reduction across SUDs such as improved physical and/or mental health and social functioning. Regulatory-focused reports are also encouraged within this overall topic of research. We encourage submission of review articles and original research reports in these areas, including novel strategies or behavioral outcomes in clinical and preclinical models. Paired-research articles from different laboratories that are investigating similar behavioral outcomes in clinical and preclinical models are highly encouraged. If submitting paired articles, authors are also invited to submit a comment on that set of articles. Non-human animal research that is translatable to the human condition and human research that can be back-translated to a nonhuman model are encouraged. Papers addressing a variety of substances, including alcohol, marijuana, stimulants, and opiates, and their disorders, are welcome.

 

Researchers in this area may submit review articles or primary research reports to Experimental and Clinical Psychopharmacology to be considered for inclusion in this special issue. Manuscripts should be submitted as usual through the APA Online Submission Portal (http://pha.edmgr.com/), and the cover letter should indicate that the authors wish the manuscript to be considered for publication in the special issue: Utilizing translational approaches to advance harm reduction strategies for substance use disorders.  All submissions will undergo our normal peer review. Manuscripts received no later than October 1, 2020 will be considered for inclusion in the special issue. We strongly encourage individuals to contact the guest editors in advance with their ideas and a draft the title and abstract.

 

Questions or inquiries about the special issue can be directed to the Guest Editors of the issue, Cassandra Gipson, PhD, at cdgips2@uky.edu or Andrew Huhn, PhD, at ahuhn1@jhu.edu, or the Editor, William W. Stoops, PhD at William.stoops@uky.edu.

 

 

Andrew S. Huhn, Ph.D., M.B.A.

Assistant Professor

Behavioral Pharmacology Research Unit

Department of Psychiatry and Behavioral Sciences

Johns Hopkins University School of Medicine

5510 Nathan Shock Drive

Baltimore, MD 21224

Phone: (410) 550-1971

ahuhn1@jhu.edu

[#DIV28SUPER] APA Science Student Council Call for Applications

Hi Everyone,

Please see below for information about applying to the APA Science Student Council. This is an excellent opportunity to get involved in service as a graduate student as well as to help guide scientific interests for graduate students within the broader APA organization. Please forward along to any students you think might be interested!

Best,

Justin

---------------------------------------------------------

Applications are currently being accepted for the APA Science Student Council (SSC). The SSC is a diverse group of graduate students in psychological science who advise the APA Science Directorate on how it can best serve the science student population.

 

The SSC is seeking new members in the following broad research areas to serve two-year terms (fall 2020-2022).

 

• Clinical science
• Behavioral neuroscience
• Health psychology
• Social/personality

 

The deadline is June 1, 2020. More information on the Science Student Council and eligibility to apply can be found here (https://www.apa.org/science/leadership/students/nominations). Please feel free to contact science@apa.org with any questions.

---------------------------------------------------------

Justin C. Strickland, Ph.D.
Postdoctoral Fellow
Behavioral Pharmacology Research Unit
Department of Psychiatry and Behavioral Sciences
Johns Hopkins University School of Medicine
Phone: (410) 550-1975